Skip to main content
. Author manuscript; available in PMC: 2008 Jul 1.
Published in final edited form as: Anticancer Res. 2007;27(4A):1897–1900.

Table I.

Receiver operator characteristic (ROC) curve analyses for patients with metastatic uveal melanoma to the liver compared with controls and patients with treated primary uveal melanomas disease-free for 10 years

Osteopontin S-100β MIA % area under the curve (AUC)
Metastases vs. Controls Metastases vs. Disease-Free
- 70 73
- 85 77
- 76 88
- - 83 85
- - 81 82
- - 84 84
- - - 87 91